ARLINGTON, VA / ACCESSWIRE / July 24, 2024 / Vannadium, Inc., a leader in advanced blockchain and DeepTech innovation, is pleased to announce that Dr. Newton Howard, renowned neuroscientist and professor at MIT, has joined the company as an advisor. Dr. Howard's pioneering work in the field of neuroscience, particularly his efforts to combat neurological disorders like Alzheimer's and Parkinson's, aligns seamlessly with Vannadium's mission to leverage their cutting-edge technology to benefit society.
Dr. Howard brings a wealth of knowledge and visionary leadership to Vannadium. His extensive background in computational neuroscience and brain signal translation aligns seamlessly with Vannadium's technology solutions. He is currently working on a project at MIT to decode brain signals that will aid in developing new treatments for neurological conditions.
Vannadium's Diffusion™ technology, a revolutionary networking protocol, provides the speed, security, and scalability required for real-time data transfer and analysis, which is essential for Dr. Howard's research. Unlike traditional blockchain systems that rely on hardware, making them slow, expensive, and difficult to scale, Diffusion™ leverages software to achieve unprecedented performance. This ensures that Vannadium can offer a solution that is both fast and cost-effective without compromising security. The innovative algorithm used in Diffusion™ not only enhances data integrity but also improves security beyond standard decentralized networks by efficiently recognizing and moving data.
In addition, Vanadium's Atomic23™ supports efficient data management and analysis, helping Dr. Howard to organize and interpret the large volumes of data involved in his brain research. Its scalability ensures that the technology can handle the extensive data requirements of his research projects without sacrificing performance. Furthermore, Vannadium's solutions facilitate better collaboration by securely managing data and allowing for seamless sharing among researchers.
"Joining forces with Vannadium allows us to accelerate the development of innovative solutions to some of the most pressing neurological challenges of our time. Vannadium's state-of-the-art blockchain technology and data management solutions will be instrumental in our quest to decode and treat mental health disorders more effectively and efficiently," said Dr. Newton Howard.
Vannadium CEO Rick Gilchrist is also enthusiastic about the partnership,"We feel very fortunate to be working with Dr. Howard and look forward to a long relationship. His expertise and impactful work in neuroscience perfectly complement our technological innovations. Together, we will make significant strides in helping millions of people worldwide who battle with mental health disorders."
About Vannadium:
Vannadium, Inc. is a pioneering DeepTech company featuring innovative products including Diffusion™, a patent-pending Web 3 protocol revolutionizing traditional data transfer and protection by evolving how we move data. This innovation unlocks the full potential of blockchain and Distributed Ledger Technology (DLT), expertly addressing previous barriers of scale, speed, energy consumption, and cost. Vannadium's unique approach to harnessing speed and scalability on the blockchain offers an unprecedented Blockchain-and-Data-as-a-Service (BaDaaS) solution, allowing organizations of any size to offer real-time utilization for their consumers. Diffusion™ allows for true data utility and real-time insights written to an immutable ledger, with guaranteed data integrity and provenance. Data sovereignty for all humanity; welcome to Web 4.0 with Vannadium.
Contact Information:
Company: Vannadium, Inc.
Contact: Larry Mercado, SVP Business Development
Email: larry@Vannadium.com
Address: New York, NY
Website: vannadium.com
SOURCE: Vannadium, Inc.
View the original press release on accesswire.com
